Back to top
more

ALPS Medical Breakthroughs ETF: (SBIO)

(Delayed Data from NYSE) As of Aug 25, 2026 03:40 PM ET

$70.14 USD

70.14
85,103

+1.50 (2.19%)

Volume: 85,103

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $70.18 +0.04 (0.06 %) 6:32 PM ET

Zacks News

Sweta Killa headshot

5 Small-Cap ETFs at the Forefront of the 2021 Market Rally

We have presented five ETFs that are easily crushing the Russell 2000 Index this year and are likely to continue their strong performance at least in the near term.

Sweta Jaiswal, FRM headshot

A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Sweta Killa headshot

5 Small-Cap Sector ETFs Beating the Russell 2000

We have presented five ETFs that have easily crushed the Russell 2000 Index over the past three months.

Sweta Killa headshot

Biotech ETF (SBIO) Hits a New 52-Week High

This biotech ETF hits a new 52-week high. Are more gains in store for this ETF?

Sanghamitra Saha headshot

Can Small-Cap ETFs Keep Up the Winning Trend in November?

The month of October was downbeat for Wall Street due to election uncertainty, failed stimulus talks, subdued tech earnings and rising coronavirus cases on the global front.

Sweta Killa headshot

5 Sector ETFs That Showed Strength Despite the Worst October

Wall Street registered its first back-to-back monthly loss of this year, with Dow Jones closing out the worst month since March.

Sweta Killa headshot

Healthcare ETFs Pop on Bristol Myers-MyoKardia Deal

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

Sweta Killa headshot

New GERM ETF Launched to Tap the Growing Biotech Sector

GERM invests in the hottest emerging biotechnology trends.

Sanghamitra Saha headshot

Don't "Bet Against the American Economy:" ETF Areas to Win

Fed Chair Powell expressed optimism about the U.S. economic recovery over the long term. These ETF areas should benefit ahead.

    Sanghamitra Saha headshot

    Follow Warren Buffett With 5 ETF Strategies & Tackle COVID-19

    Follow Warren Buffett???s latest COVID-19-fighting tips with these ETF strategies.